Methods are described for the isolation of nucleic acid ligands to integrins using the SELEX process. SELEX is an acronym for Systematic Evolution of Ligands by EXponential enrichment. The nucleic acid ligands of the present invention are useful as therapeutic and diagnostic agents.

 
Web www.patentalert.com

< Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders

< Method and system for myocardial infarction repair

> Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74

> Targeted therapeutics and uses thereof
~ 00284